Thomas E Witzig, M.D.

Rare Disease Specialist

Mayo Clinic Health Systems-Mankato

Mankato, Minnesota

Last updated· March 2026

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement

Clinical trials (1)

NCT03418038

Verify independently

ClinicalTrials.gov PI search for Thomas E Witzig, M.D.

Other specialists for High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement

Peers ranked by clinical-trial PI role, publications, and verification quality.

Stephen M Ansell, M.D
Dana-Farber - Harvard Cancer Center LAO
MN
Reem Karmali, MD, MD
Northwestern University
IL

See all specialists for High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement →

← Back to specialists directory